Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Nereus Pharmaceuticals
company
About
Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.
- 11 - 50
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $42.60M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 1998
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$107.60M
Nereus Pharmaceuticals has raised a total of
$107.60M
in funding over 2 rounds. Their latest funding was raised on
Jun 25, 2010 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 25, 2010 | Series E | $20M | 1 | — | — | Detail |
| Aug 9, 2007 | Series D | $45M | 4 |
BankInvest Biomedical Venture
|
— | Detail |
| Oct 19, 2005 | Series D | $42.60M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
Nereus Pharmaceuticals is funded by 6 investors.
BankInvest Biomedical Venture
and Advent International
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
BankInvest Biomedical Venture
|
Yes | Series D |
Advent International
|
— | Series E |
|
|
— | Series D |
|
|
— | Series D |
Sanofi
|
— | Series D |
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
